Literature DB >> 20577841

Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy.

Yasushi Ishida1, Naoko Sakamoto, Kiyoko Kamibeppu, Naoko Kakee, Tsuyako Iwai, Shuichi Ozono, Naoko Maeda, Jun Okamura, Keiko Asami, Hiroko Inada, Misato Honda, Keizo Horibe.   

Abstract

To examine the late effects and health-related quality of life of childhood cancer survivors (CCS) after radiotherapy (RT), we performed a cross-sectional survey using self-rating questionnaires. The subjects were divided into 3 groups: CCS treated with or without RT, and a general population matched for age, gender, residential area, and work status. The numbers in each group were 113, 72, and 1,000, respectively. The median ages of CCS at diagnosis and the time of the survey were 8 and 22 years, respectively. The mean final heights of males and females were significantly lower in CCS with RT than in the other 2 groups. Risk factors for a short stature were total body irradiation (TBI) [odds ratio (OR) 17.8, p < 0.001], spinal irradiation (OR 8.31, p = 0.033), and an age younger than 10 years at diagnosis. Late effects were observed in 68% of CCS with RT compared with 36% of CCS without RT. Multivariate analysis revealed that TBI was significantly associated with endocrine dysfunction (OR 12.3), skull and spinal irradiation with cognitive dysfunction (OR 16.1 and 11.5, respectively), and spinal irradiation with a short stature (OR 14.1), respectively. Physical dysfunction, psychological stress, and problems of social adaptation were observed in >50% of CCS with RT.

Entities:  

Mesh:

Year:  2010        PMID: 20577841     DOI: 10.1007/s12185-010-0611-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.

Authors:  Eric J Chow; Debra L Friedman; Yutaka Yasui; John A Whitton; Marilyn Stovall; Leslie L Robison; Charles A Sklar
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

2.  Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Authors:  Maud M Geenen; Mathilde C Cardous-Ubbink; Leontien C M Kremer; Cor van den Bos; Helena J H van der Pal; Richard C Heinen; Monique W M Jaspers; Caro C E Koning; Foppe Oldenburger; Nelia E Langeveld; Augustinus A M Hart; Piet J M Bakker; Huib N Caron; Flora E van Leeuwen
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

Review 3.  Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings.

Authors:  Lisa Diller; Eric J Chow; James G Gurney; Melissa M Hudson; Nina S Kadin-Lottick; Toana I Kawashima; Wendy M Leisenring; Lillian R Meacham; Ann C Mertens; Daniel A Mulrooney; Kevin C Oeffinger; Roger J Packer; Leslie L Robison; Charles A Sklar
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

4.  Adult height and age at menarche in childhood cancer survivors.

Authors:  E M Noorda; R Somers; F E van Leeuwen; T Vulsma; H Behrendt
Journal:  Eur J Cancer       Date:  2001-03       Impact factor: 9.162

Review 5.  High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance.

Authors:  Melissa M Hudson; Daniel A Mulrooney; Daniel C Bowers; Charles A Sklar; Daniel M Green; Sarah S Donaldson; Kevin C Oeffinger; Joseph P Neglia; Anna T Meadows; Leslie L Robison
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

6.  Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study.

Authors:  Carrie M Brownstein; Ann C Mertens; Pauline A Mitby; Marilyn Stovall; Jing Qin; Glenn Heller; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

7.  Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention.

Authors:  J W Han; S Y Kwon; S C Won; Y J Shin; J H Ko; C J Lyu
Journal:  Ann Oncol       Date:  2009-03-06       Impact factor: 32.976

8.  The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information.

Authors:  M M Hawkins; E R Lancashire; D L Winter; C Frobisher; R C Reulen; A J Taylor; M C G Stevens; M Jenney
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

9.  Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.

Authors:  J P Neglia; D L Friedman; Y Yasui; A C Mertens; S Hammond; M Stovall; S S Donaldson; A T Meadows; L L Robison
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 11.816

10.  Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study.

Authors:  James G Gurney; Kirsten K Ness; Marilyn Stovall; Suzanne Wolden; Judy A Punyko; Joseph P Neglia; Ann C Mertens; Roger J Packer; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 6.134

View more
  15 in total

1.  Social outcomes and quality of life of childhood cancer survivors in Japan: a cross-sectional study on marriage, education, employment and health-related QOL (SF-36).

Authors:  Yasushi Ishida; Misato Honda; Kiyoko Kamibeppu; Shuichi Ozono; Jun Okamura; Keiko Asami; Naoko Maeda; Naoko Sakamoto; Hiroko Inada; Tsuyako Iwai; Naoko Kakee; Keizo Horibe
Journal:  Int J Hematol       Date:  2011-04-26       Impact factor: 2.490

2.  Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution.

Authors:  Francesco Felicetti; Rosaria Manicone; Andrea Corrias; Chiara Manieri; Eleonora Biasin; Ilaria Bini; Giuseppe Boccuzzi; Enrico Brignardello
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-16       Impact factor: 4.553

3.  FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.

Authors:  Mamata Singh; Justin M Leasure; Christopher Chronowski; Brian Geier; Kathryn Bondra; Wenrui Duan; Lauren A Hensley; Miguel Villalona-Calero; Ning Li; Anthony M Vergis; Raushan T Kurmasheva; Changxian Shen; Gary Woods; Nikhil Sebastian; Denise Fabian; Rita Kaplon; Sue Hammond; Kamalakannan Palanichamy; Arnab Chakravarti; Peter J Houghton
Journal:  Clin Cancer Res       Date:  2014-04-30       Impact factor: 12.531

4.  Using three legacy measures to develop a health-related quality of life tool for young adult survivors of childhood cancer.

Authors:  I-Chan Huang; Gwendolyn P Quinn; Pey-Shan Wen; Elizabeth A Shenkman; Dennis A Revicki; Kevin Krull; Zhushan Li; Patricia D Shearer
Journal:  Qual Life Res       Date:  2011-11-20       Impact factor: 4.147

5.  Head-to-head comparisons of quality of life instruments for young adult survivors of childhood cancer.

Authors:  I-Chan Huang; Gwendolyn P Quinn; Kevin Krull; Katie Z Eddleton; Devin C Murphy; Elizabeth A Shenkman; Patricia D Shearer
Journal:  Support Care Cancer       Date:  2011-11-22       Impact factor: 3.603

6.  The application of radiation therapy to the Pediatric Preclinical Testing Program (PPTP): results of a pilot study in rhabdomyosarcoma.

Authors:  Rita Kaplon; Mersiha Hadziahmetovic; Jim Sommerfeld; Kathryn Bondra; Lanchun Lu; Justin Leasure; Phuong Nguyen; Kelsey McHugh; Ning Li; Christopher Chronowski; Nikhil Sebastian; Mamta Singh; Raushan Kurmasheva; Peter Houghton; Christopher E Pelloski
Journal:  Pediatr Blood Cancer       Date:  2012-06-12       Impact factor: 3.167

7.  Evaluation of volumetric modulated arc therapy (VMAT) - based total body irradiation (TBI) in pediatric patients.

Authors:  Kadir Yaray; Edrine Damulira
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

Review 8.  Late endocrine effects of childhood cancer.

Authors:  Susan R Rose; Vincent E Horne; Jonathan Howell; Sarah A Lawson; Meilan M Rutter; Gylynthia E Trotman; Sarah D Corathers
Journal:  Nat Rev Endocrinol       Date:  2016-04-01       Impact factor: 43.330

9.  Cyclophosphamide inhibits root development of molar teeth in growing mice.

Authors:  Tomomi Kawakami; Yuko Nakamura; Hiroyuki Karibe
Journal:  Odontology       Date:  2014-06-03       Impact factor: 2.634

10.  Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children.

Authors:  Lisa M Madden; Alexander I Ngwube; Shalini Shenoy; Todd E Druley; Robert J Hayashi
Journal:  J Pediatr Hematol Oncol       Date:  2015-03       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.